Pillar5 Pharma is a Canadian CDMO founded in 2009, specializing in sterile ophthalmic manufacturing and solid dose production. Market leader in Multi-Dose Preservative Free (MDPF) technology in North America. Produces 30 million ophthalmic bottles and 255 million solid dose tablets per year with 210+ employees. Acquired by ANJAC Sante & Beaute and is also a Prestige Consumer Healthcare company. Health Canada approved, holds FDA Drug Establishment Registration. Acquired former Pfizer site in Arnprior, Ontario.
Multi-Dose Preservative Free (MDPF) ophthalmic manufacturing, sterile ophthalmic solutions, solid dose tablet manufacturing, technical transfer, sterility assurance, microbiology
1 site worldwide
No reviews available yet.
No documents available.